Biopharma | April 21, 2026
Samsung Bioepis unveils promising preclinical data for novel ADC SBE303 at AACR 2026
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers


